Luc Mainville

Luc Mainville is the SVP, Chief Financial Officer at Ortho Regenerative Technologies. Luc has over 20 years of experience in the pharmaceutical and biotech industries.

Mainville began their career at Valeo Pharma Inc., where they held various positions including Interim President and Chief Executive Officer. Luc then joined PIGA Inc. as Operating Chairman, and later became a Board Member at AAA Médic Montréal. In August 2017, they joined Zucara Therapeutics Inc. as Chairman.

Mainville holds a Bachelor of Science in Finance from the Université du Québec à Montréal and is a Certified Management Accountant (CMA).

Luc Mainville has an MBA from McGill University in international marketing & finance and a master's degree in business administration from UQAM.

Some of their coworkers include Guy Paul Allard - VP, Legal Affairs & Corporate Secretary. Luc Mainville reports to Claude Leduc, Chief Executive Officer.